Topoisomerase II inhibitor-related acute myeloid leukaemia

British Journal of Haematology

Volumn 109, Issue 1, 2000, Pages 13-23

  Pui, Ching Hon ^a,b   Relling, Mary V ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

11q23 translocations; Anthracyclines; Epipodophyllotoxins; MLL rearrangement; Therapy related acute myeloid leukaemia

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN DERIVATIVE; EPIPODOPHYLLOTOXIN; ETOPOFOS; GYRASE INHIBITOR; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PIPERAZINE DERIVATIVE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHROMOSOME ABERRATION; CLINICAL FEATURE; HUMAN; LEUKEMOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

EID: 0034034557     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01843.x     Document Type: Review

References (121)

1. Albain, K.S., Le Beau, M.M., Ullirsch, R. & Schumacher, H. (1990) Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. Genes, Chromosomes and Cancer, 2, 53-58.
2. Amylon, M.D., Shuster, J., Pullen, J., Berard, C., Link, M.P., Wharam, M., Katz, J., Yu, A., Laver, J., Ravindranath, Y., Kurtzberg, J., Desai, S., Camitta, B. & Murphy, S.B. (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia, 13, 335-342.
3. Andersen, M.K., Johansson, B., Larsen, S.O. & Pedersen-Bjergaard, J. (1998) Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica, 83, 483-488.
4. Andersson, M., Philip, P. & Pedersen-Bjergaard, J. (1990) High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer. Cancer, 65, 2460-2464.
5. Aplan, P.D., Chervinsky, D.S., Stanulla, M. & Burhans, W.C. (1996) Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood, 87, 2649-2658.
6. Archimbaud, E., Charrin, C., Magaud, J.P., Campos, L., Thomas, X., Fiere, D. & Rimokh, R. (1998) Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Leukemia, 12, 25-33.
7. Arnold, R., de Witte, T., van Biezen, A., Hermans, J., Jacobsen, N., Runde, V., Gratwohl, A. & Apperley, J.F. (1998) Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group. Bone Marrow Transplantation, 21, 1213-1216.
8. Atlas, M., Head, D., Behm, F., Schmidt, E., Zeleznik-Le, N.H., Roe, B.A., Burian, D. & Domer, P.H. (1998) Cloning and sequence analysis of four t (9;11) therapy-related leukemia breakpoints. Leukemia, 12, 1895-1902.
9. Bajorin, D.F., Motzer, R.J., Rodriguez, E., Murphy, B. & Bosl, G.J. (1993) Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy. Journal of the National Cancer Institute, 85, 60-62.
10. Bokemeyer, C. & Schmoll, H.J. (1995) Treatment of testicular cancer and the development of secondary malignancies. Journal of Clinical Oncology, 13, 283-292.
11. Bokemeyer, C., Schmoll, H.J., Kuczyk, M.A., Beyer, J. & Siegert, W. (1995) Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer. Journal of the National Cancer Institute, 87, 58-60.
12. Boshoff, C., Begent, R.H., Oliver, R.T., Rustin, G.J., Newlands, E.S., Andrews, R., Skelton, M., Holden, L. & Ong, J. (1995) Secondary tumours following etoposide containing therapy for germ cell cancer. Annals of Oncology, 6, 35-40.
13. Broeker, P.L., Super, H.G., Thirman, M.J., Pomykala, H., Yonebayashi, Y., Tanabe, S., Zeleznik-Le, N. & Rowley, J.D. (1996) Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood, 87, 1912-1922.
14. Cavalli-Sforza, L.L. (1998) The DNA revolution in population genetics. Trends in Genetics, 14, 60-65.
15. Chen, C.-L., Fuscoe, J.C., Liu, Q. & Relling, M.V. (1996a) Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells. Blood, 89, 2210-2218.
16. Chen, C.-L., Fuscoe, J.C., Liu, Q., Pui, C.-H., Mahmoud, H.H. & Relling, M.V. (1996b) Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide. Journal of the National Cancer Institute, 88, 1840-1847.
17. Chiang, P.K., Gordon, R.K., Tal, J., Zeng, G.C., Doctor, B.P., Pardhasaradhi, K. & McCann, P.P. (1996) S-Adenosylmethionine and methylation. FASEB Journal, 10, 471-480.
18. Cimino, G., Moir, D.T., Canaani, O., Williams, K., Crist, W.M., Katzav, S., Cannizzaro, L., Lange, B., Nowell, P.C. & Croce, C.M. (1991) Cloning of ALL-1, the locus involved in leukemias with the t(4:11) (q21;q23). 1(9;11) (p22;q23), and t(11;19) (q23:p13) chromosome translocations. Cancer Research, 51, 6712-6714.
19. Cimino, G., Rapanotti, M.C., Biondi, A., Elia, L., Lo Coco, F., Price, C.M., Rossi, V., Rivolta, A., Canaani, E., Croce, C.M., Mandelli, F. & Greaves, M. (1997) Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Research, 57, 2879-2883.
20. Corral, J., Lavenir, I., Impey, H., Warren, A.J., Forster, A., Larson, T.A., Bell, S., McKenzie, A.N., King, G. & Rabbitts, T.H. (1996) An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell, 85, 853-861.
21. Cortes, J., O'Brien, S., Kantarjian, H., Cork, A., Stass, S., Freireich, E.J., Keating, M., Pierce, S. & Estey, E. (1994) Abnormalities in the long arm of chromosome 11(11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. Leukemia, 8, 2174-2178.
22. Detourmignies, L., Castaigne, S., Stoppa, A.M., Harousscau, J.L., Sadoun, A., Janvier, M., Demory, J.L., Sanz, M., Bergen, R., Bauters, F., Chomienne, C. & Fenaux, P. (1992) Therapy-related acute promyelocytic leukemia: a report on 16 cases. Journal of Clinical Oncology, 10, 1430-1435.
23. DeVore, R., Whitlock, J., Hainsworth, J.D. & Johnson, D.H. (1989) Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q. Annals of Internai Medicine, 110, 740-742.
24. DiMartino, J.F. & Cleary, M.L. (1999) MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. British Journal of Haematology, 106, 614-626.
25. Dissing, M., Le Beau, M.M. & Pedersen-Bjergaard, J. (1998) Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors? Journal of Clinical Oncology, 16, 1890-1896.
26. Djabali, M., Sellen, L., Parry, P., Bower, M., Young, B.D. & Evans, G.A. (1992) A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nature Genetics, 2, 113-118.
27. Domer, P.H., Head, D.R., Renganathan, N., Raimondi, S.C., Yang, E. & Atlas. M. (1995) Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Leukemia, 9, 1305-1312.
28. Downing, J.R. & Look, A.T. (1996) MLL fusion genes in the 11q23 acute leukemias. Cancer Treatment Research, 84, 73-92.
29. Felix, C.A., Walker, A.H., Lange, B.J., Williams, T.M., Winick, N.J., Cheung, N.K., Lovett, B.D., Nowell, P.C., Blair, I.A. & Rebbeck, T.R. (1998) Association of CYP3A4 genotype with treatment-related leukemia. Proceedings of the National Academy of Sciences USA, 95, 13176-13181.
30. Felix, C.A., Winick, N.J., Negrini, M., Bowman, W.P., Croce, C.M. & Lange, B.J. (1993) Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia. Cancer Research, 53, 2954-2956.
31. Fidanza, V., Melotti, P., Yano, T., Nakamura, T., Bradley, A., Canaani, E., Calabretta, B. & Croce, C.M. (1996) Double knock-out of the ALL-1 gene blocks hematopoietic differentiation in vitro. Cancer Research, 56, 1179-1183.
32. Fry, D.W. (1990) Cytotoxic synergism between trimetrexate and etoposide. Evidence that trimetrexate potentiates etoposide-induced protein-associated DNA strand breaks in L1210 leukemia cells through alterations in intracellular ATP concentrations. Biochemical Pharmacology, 40, 1981-1988.
33. Gill Super, H.J., Rothberg, P.G., Kobayashi, H., Freeman, A.I., Diaz, M.O. & Rowley, J.D. (1994) Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. Blood, 83, 641-644.
34. Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H., Champlin, R. & Korbling, M. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89, 4531-4536.
35. Gu, Y., Alder, H., Nakamura, T., Schichman, S.A., Prasad, R., Canaani, O., Saito, H., Croce, C.M. & Canaani, E. (1994) Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Research, 54, 2326-2330.
36. Gu, Y., Cimino, G., Alder, H., Nakamura, T., Prasad, R., Canaani, O., Moir, D.T., Jones, C., Nowell, P.C., Croce, C.M. & Canaani, E. (1992b) The (4;11) (q21:q23) chromosome translocations in acute leukemias involve the VUJ recombinase. Proceedings of the National Academy of Sciences USA, 89, 10464-10468.
37. Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C.M. & Canaani, E. (1992a) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell, 71, 701-708.
38. Hale, G.A., Heslop, H.E., Bowman, L.C., Rochester, R.M., Pui, C.-H., Brenner, M.K. & Krance, R.A. (1999) Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies. Bone Marrow Transplantation, 24, 735-739.
39. Haupt, R., Fears, T.R., Heise, A., Gadner, H., Loiacono, G., de Terlizzi, M. & Tucker, M.A. (1997) Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations. International Journal of Cancer, 71, 9-13.
40. Hawkins, M.M., Wilson, L.M., Stovall, M.A., Marsden, H.B., Potok, M.H., Kingston, J.E. & Chessells, J.M. (1992) Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. British Medical Journal, 304, 951-958.
41. Height, S.E., Dainton, M.G., Kearney, L., Swansbury, G.J., Matutes, E., Dyer, M.J.S., Treleaven, J.G., Powles, R.L. & Catovsky, D. (1994) Acute myelomonocytic leukemia with t(10;11) (p13:q23): heterogeneity of breakpoints at 11q23 with recombinase activation. Genes, Chromosomes and Cancer, 11, 136-139.
42. Hess, J.L., Yu, B.D., Li, B., Hanson, R. & Korsmeyer, S.J. (1997) Defects in yolk sac hematopoiesis in Mll-null embryos. Blood, 90, 1799-1806.
43. Heyn, R., Khan, F., Ensign, L.G., Donaldson, S.S., Ruymann, F., Smith, M.A., Vietti, T. & Maurer, H.M. (1994) Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report. Medical and Pediatric Oncology, 23, 99-106.
44. Horibe, K., Matsushita, T., Numata, S., Miyajima, Y., Katayama, I., Kitabayashi, T., Yanai, M., Sekiguchi, N. & Egi, S. (1993) Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer, 72, 3723-3726.
45. Hunger, S.P., Sklar, J. & Link, M.P. (1992) Acute lymphoblastic leukemia occurring as a second malignant neoplasma in childhood: report three cases and review of the literature. Journal of Clinical Oncology 10, 156-163.
46. James, S.J., Basknakian, A.G. & Miller, B.J. (1994) In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Research, 54, 5075-5080.
47. Kakihara, T., Tanaka, A., Kataoka, S., Yamamoto, K., Okada, R., Watanabe, A., Uchiyama, M. & Kishi, K. (1996) Differentiation induction therapy with all-trans retinoic acid (ATRA) in a patient with secondary 11q23 leukemia. Journal of Pediatric Hematology and Oncology, 18, 405-408.
48. Kollmannsberger, C., Beyer, J., Droz, J.P., Harstrick, A., Hartmann, J.T., Biron, P., Flechon, A., Schoffski, P., Kuczyk, M., Schmoll, H.J., Kanz, L. & Bokemeyer, C. (1998) Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. Journal of Clinical Oncology, 16, 3386-3391.
49. Kudo, K., Yoshida, H., Kiyoi, H., Numata, S., Horibe, K. & Naoe, T. (1998) Etoposide-related acute promyelocytic leukemia. Leukemia, 12, 1171-1175.
50. Kushner, B.H., Cheung, N.K., Kramer, K., Heller, G. & Jhanwar, S.C. (1998) Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. Journal of Clinical Oncology, 16, 3880-3889.
51. Leahey, A.M., Friedman, D.L. & Bunin, N. (1999) Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia. Bone Marrow Transplantation, 23, 21-25.
52. Malkin, D., Jolly, K.W., Barbier, N., Look, A.T., Friend, S.H., Gebhardt, M.C., Andersen, T.I., Borresen, A., Li, F.P., Garber, J. & Strong, L.C. (1992) Germline mutation of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. New England Journal of Medicine, 336, 1309-1315.
53. Marcucci, G., Strout, M.P., Bloomfield, C.D. & Caligiuri, M.A. (1998) Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Research, 58, 790-793.
54. Marty, M. (1993) Epirubicin and the risk of leukemia: not substantiated? International Collaborative Cancer Group Steering Committee. Journal of Clinical Oncology, 11, 1431-1433.
55. Matsuzaki, A., Inamitsu, T., Watanabe, T., Ohga, S., Ishii, E., Nagotoshi, Y., Tasaka, H., Suda, M. & Ueda, K. (1994) Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis. British Journal of Haematology, 86, 887-889.
56. Matthews, D.C., Appelbaum, F.R., Eary, J.F., Fisher, D.R., Durack, L.D., Bush, S.A., Hui, T.E., Martin, P.J., Mitchell, D. & Press, O.W. (1995) Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 1311-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood, 85, 1122-1131.
57. Megonigal, M.D., Rappaport, E.F., Jones, D.H., Williams, T.M., Lovett, B.D., Kelly, K.M., Lerou, P.H., Moulton, T., Budarf, M.L. & Felix, C.A. (1998a) t(11;22) (q23:q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proceedings of the National Academy of Sciences USA, 95, 6413-6418.
58. Megonigal, M.D., Rappaport, E.F., Nowell, P.C., Lange, B.J. & Felix, C.A. (1998b) Potential role for wild-type p53 in leukemias with MLL gene translocations. Oncogene, 16, 1351-1356.
59. Nakamura, T., Alder, H., Gu, Y., Prasad, R., Canaani, O., Kamada, N., Gale, R.P., Lange, B., Crist, W.M., Nowell, P.C., Croce, C.M. & Canaani, E. (1993) Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proceedings of the National Academy of Sciences USA, 90, 4631-4635.
60. Naoe, T., Kudo, K., Yoshida, H., Horibe, K. & Ohno, R. (1997) Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia. Leukemia, 11, 287-288.
61. Negrini, M., Felix, C.A., Martin, C., Lange, B.J., Nakamura, T., Canaani, E. & Croce, C.M. (1993) Potential topoisomerase II DNA-binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia. Cancer Research, 53, 4489-4492.
62. Nichols, C.R., Breeden, E.S., Loehrer, P.J., Williams, S.D. & Einhorn, L.H. (1993) Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. Journal of the National Cancer Institute, 85, 36-40.
63. Nishiyama, M., Arai, Y., Tsunematsu, Y., Kobayashi, H., Asami, K., Yabe, M., Kato, S., Oda, M., Eguchi, H., Ohki, M. & Kaneko, Y. (1999) 11p15 translocations involving NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome. Genes, Chromosomes and Cancer, 26, 215-220.
64. Parry, P., Djabali, M., Bower, M., Khristich, J., Waterman, M., Gibbons, B., Young, B.D. & Evans, G. (1993) Structure and expression of the human trithorax-like gene 1 involved in acute leukemias. Proceedings of the National Academy of Sciences USA, 90, 4738-4742.
65. Pedersen-Bjergaard, J., Brondum-Nielsen, K., Karle, H. & Johansson, B. (1997) Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia, 11, 1571-1574.
66. Pedersen-Bjergaard, J., Daugaard, G., Hansen, S.W., Philip, P., Larsen, S.O. & Rorth, M. (1991) Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet, 338, 359-363.
67. Pedersen-Bjergaard, J., Johansson, B. & Philip, P. (1994) Translocation (3:21) (q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformation. Cancer Genetics and Cytogenetics, 76, 50-55.
68. Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Andersson, M., Daugaard, G., Ersboll, J., Hansen, S.W., Hou-Jensen, K., Nielsen, D., Sigsgaard, T.C., Specht, L. & Osterlind, K. (1993) Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia, 7, 1975-1986.
69. Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Jensen, G. & Byrsting, K. (1990) Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood, 76, 1083-1091.
70. Pedersen-Bjergaard, J. & Rowley, J.D. (1994) The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood, 83, 2780-2786.
71. Pedersen-Bjergaard, J., Sigsgaard, T.C., Nielsen, D., Gjedde, S.B., Philip, P., Hansen, M., Larsen, S.O., Rorth, M., Mouridsen, H., Dombernowsky, P. & Rrth, M. (1992) Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer. Journal of Clinical Oncology, 10, 1444-1451.
72. Prasad, R., Yano, T., Sorio, C., Nakamura, T., Rallapalli, R., Gu, Y., Leshkowitz, D., Croce, C.M. & Canaani, E. (1995) Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proceedings of the National Academy of Sciences USA, 92, 12160-12164.
73. Pratt, C.B. & Pui, C.-H. (1992) Secondary acute lymphoblastic leukemia in childhood. Journal of Clinical Oncology, 10, 866.
74. Prieto, F., Palau, F., Badia, L., Beneyto, M., Perez-Sirvent, M.L., Orts, A. & Castel, V. (1990) 11q23 abnormalities in children with acute nonlymphocytic leukemia (M4-M5). Association with previous chemotherapy. Cancer Genetics and Cytogenetics, 45, 1-11.
75. Pui, C.-H. (1991) Epipodophyllotoxin-related acute myeloid leukaemia. Lancet, 338, 1468.
76. Pui, C.-H. (1992) Acute leukemias with the t(4;11) (q21:q23). Leukemia and Lymphoma, 7, 173-179.
77. Pui, C.-H., Behm, F.G., Raimondi, S.C., Dodge, R.K., George, S.L., Rivera, G.K., Mirro, J. Jr, Kalwinsky, D.K., Dahl, G.V., Murphy, S.B., Crist, W.M. & Williams, D.L. (1989) Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. New England Journal of Medicine, 321, 136-142.
78. Pui, C.-H., Hancock, M.L., Raimondi, S.C., Head, D.R., Thompson, E., Wilimas, J., Kun, L.E., Bowman, L.C., Crist, W.M. & Pratt, C.B. (1990) Myeloid neoplasia in children treated for solid tumours. Lancet, 336, 417-421.
79. Pui, C.-H., Relling, M.V., Rivera, G.K., Hancock, M.L., Raimondi, S.C., Heslop, H.E., Santana, V.M., Ribeiro, R.C., Sandlund, J.T., Mahmoud, H.H., Evans, W.E. & Krance, R.A. (1995a) Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia, 9, 1990-1996.
80. Pui, C.H., Relling, M.V., Behm, F.G., Hancock, M.L., Boyett, J.M., Raimondi, S.C., Krance, R.A., Mahmoud, H.H., Ribeiro, R.C., Sandlund, J.T., Head, D.R. & Evans, W.E., (1995b) L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins. Leukemia, 9, 1680-1684.
81. Pui, C.-H., Ribeiro, R.C., Hancock, M.L., Rivera, G.K., Evans, W.E., Raimondi, S.C., Head, D.R., Behm, F.G., Mahmoud, M.H., Sandlund, J.T. & Crist, W. (1991) Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphocytic leukemia. New England Journal of Medicine, 325, 1682-1687.
82. Quesnel, B., Kantarjian, H., Bjergaard, J.P., Brault, P., Estey, E., Lai, J.L., Tilly, H., Stoppa, A.M., Archimbaud, E. & Harousseau, J.L. (1993) Therapy-related acute myeloid leukemia with t(8;21). inv(16), and t(8;16): a report on 25 cases and review of the literature. Journal of Clinical Oncology, 11, 2370-2379.
83. Rasio, D., Schichman, S.A., Negrini, M., Canaani, E. & Croce, C.M. (1996) Complete exon structure of the ALL1 gene. Cancer Research, 56, 1766-1769.
84. Ratain, M.J., Kaminer, L.S., Bitran, J.D., Larson, R.A., LeBeau, M.M., Skosey, C., Purl, S., Hoffman, P.C., Wade, J., Vardiman, J.W., Kaly, K., Rowley, J.D. & Golomb, H.M. (1987) Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood, 70, 1412-1417.
85. Ratain, M.J. & Rowley, J.D. (1992) Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. Annals of Oncology, 3, 107-111.
86. Relling, M.V., Yanishevski, Y., Nemec, J., Evans, W.E., Boyett, J.M., Behm, F.G. & Pui, C.H. (1998) Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia, 12, 346-352.
87. Riggi, M. & Riva, A. (1993) Therapy-related leukemia: what is the role of 4-epi-doxorubicin? Journal of Clinical Oncology, 11, 1430-1431.
88. Ross, J.A., Potter, J.D. & Robison, L.L. (1994) Infant leukemia, topoisomerase II inhibitors, and the MLL gene. Journal of the National Cancer Institute, 86, 1678-1680.
89. Rubnitz, J.E., Behm, F.G. & Downing, J.R. (1996) 11q23 rearrangements in acute leukemia. Leukemia, 10, 74-82.
90. Sandier, E.S., Friedman, D.J., Mustafa, M.M., Winick, N.J., Bowman, W.P. & Buchanan, G.R. (1997) Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia. Cancer, 79, 1049-1054.
91. Sandoval. C., Pui, C.-H., Bowman, L.C., Heaton, D., Hurwitz, C.A., Raimondi, S.C., Behm, F.G. & Head, D.R. (1993) Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. Journal of Clinical Oncology, 11, 1039-1045.
92. Santana, V.M., Hurwitz, C.A., Blakley, R.L., Crom, W.R., Luo, X., Roberts, W.M., Ribeiro, R., Mahmoud, H. & Krance, R.A. (1994) Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia. Blood, 84, 1237-1242.
93. Schichman, S.A., Caligiuri, M.A., Strout, M.P., Carter, S.L., Gu, Y., Canaani, E., Bloomfield, C.D. & Croce, C.M. (1994) ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Research, 54, 4277-4280.
94. Schnittger, S., Wormann, B., Hiddemann, W. & Griesinger, F. (1998) Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood, 92, 1728-1734.
95. Secker-Walker, L.M., Moorman, A.V., Bain, B.J. & Mehta, A.B. (1998) Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. Leukemia, 12, 840-844.
96. Smith, M.A., McCaffrey, R.P. & Karp, J.E. (1996) The secondary leukemias: challenges and research directions. Journal of the National Cancer Institute, 88, 407-418.
97. Smith, M.A., Rubinstein, L., Anderson, J.R., Arthur, D., Catalano, P.J., Freidlin, B., Heyn, R., Khayat, A., Krailo, M., Land, V.J., Miser, J., Shuster, J. & Vena, D. (1999) Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. Journal of Clinical Oncology, 17, 569-577.
98. Smith, M.A., Rubinstein, L. & Ungerleider, R.S. (1995) Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks. Medical Pediatrics and Oncology, 23, 86-98.
99. So, C.W., Ma, Z.G., Price, C.M., Dong, S., Chen, S.J., Gu, L.J., So, C.K., Wiedemann, L.M. & Chan, L.C. (1997) MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Research, 57, 117-122.
100. Slanulla, M., Wang, J., Chervinsky, D.S. & Aplan, P.D. (1997a) Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus. Leukemia, 11, 490-496.
101. Stanulla, M., Wang, J., Chervinsky, D.S., Thandla, S. & Aplan, P.D. (1997b) DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Molecular & Cellular Biology, 17, 4070-4079.
102. Stanulla, M., Schunemann, H.J., Thandla, S., Brecher, M.L. & Aplan, P.D. (1998) Pseudo-rearrangement of the MLL gene at chromosome 11q23: a cautionary note on genotype analysis of leukaemia patients. Molecular Pathology, 51, 85-89.
103. Stine, K.C., Saylors, R.L., Sawyer, J.R. & Becton, D.L. (1997) Secondary acute myelogenous leukemia following safe exposure to etoposide. Journal of Clinical Oncology, 15, 1583-1586.
104. Strissel, P.L., Strick, R., Rowley, J.D. & Zeleznik-Le, N.J. (1998) An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood. 92, 3793-3803.
105. Sugita, K., Furukawa, T., Tsuchida, M., Okawa, Y., Nakazawa, S., Akatsuka, J., Ohira, M. & Nishimura, K. (1993) High frequency of etoposide-related secondary leukemia in children with non-Hodgkin's lymphoma. American Journal of Pediatric Hematology/Oncology, 15, 99-104.
106. Super, H.J., McCabe, N.R., Thirman, M.J., Larson, R.A., Le Beau, M.M., Pedersen-Bjergaard, J., Philip, P., Diaz, M.O. & Rowley, J.D. (1993) Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood, 82, 3705-3711.
107. Super, H.G., Strissel, P.L., Sobulo, O.M., Burian, D., Reshmi, S.C., Roe, B., Zeleznik-Le, N.J., Diaz, M.O. & Rowley, J.D. (1997) Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes, Chromosomes and Cancer, 20, 185-195.
108. Thirman, M.J., Gill, H.J., Burnett, R.C., Mbangkollo, D., McCabe, N.R., Kobayashi, H., Ziemin-van der Poel, S., Kaneko, Y., Morgan, R., Sandberg, A.A., Chaganti, R.S.K., Larson, R.A., LeBeau, M.M., Diaz, M.O. & Rowley, J.D. (1993) Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. New England Journal of Medicine, 329, 909-914.
109. Tkachuk, D.C., Kohler, S. & Cleary, M.L. (1992) Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell, 71, 691-700.
110. Uckun, F.M., Herman-Hatten, K., Crotty, M.L., Sensel, M.G., Sather, H.N., Tuel-Ahlgren, L., Sarquis, M.B., Bostrom, B., Nachman, J.B., Steinherz, P.G., Gaynon, P.S. & Heerema, N. (1998) Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11) (q21:q23) chromosomal translocation. Blood, 92, 810-821.
111. Verdeguer, A., Ruiz, J.G., Ferris, J., Esquembre, C., Tasso, M.J., Hernandez, J.M., Prieto, F. & Castel, V. (1992) Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide. Medical and Pediatric Oncology, 20, 48-52.
112. Weisburger, E.K. (1977) Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents. Cancer, 40, 1935-1949.
113. Whitlock, J.A. . Greer, J.P. & Lukens, J.N. (1991) Epipodophyllotoxin-relaled leukemia. Identification of a new subset of secondary leukemia. Cancer, 68, 600-604.
114. Winick, N.J., McKenna, R.W., Shuster, J.J., Schneider, N.R., Borowitz, M.J., Bowman, W.P., Jacaruso, D., Kamen, B.A. & Buchanan, G.R. (1995) Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. Journal of Clinical Oncology, 11, 209-217.
115. Woo, M.H., Shuster, J.J., Chen, C.-L., Bash, R.J., Behm, F.G., Camitta, B., Felix, C.A., Kamen, B.A., Pui, C.-H., Raimondi, S.C., Winick, N.J., Amylon, M.D. & Relling, M.V. (2000) Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid neoplasias. Leukemia, (in press).
116. Xue, Y., Lu, D., Guo, Y. & Lin, B. (1992) Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis. Leukemia Research, 16, 1113-1123.
117. Yagita, M., Ieki, Y., Onishi, R., Huang, C.L., Adachi, M., Horiike, S., Konaka, Y., Taki, T. & Miyake, M. (1998) Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer. International Journal of Oncology, 13, 91-96.
118. Yu. B.D., Hanson, R.D., Hess, J.L., Horning, S.E. & Korsmeyer, S.J. (1998) MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morpho-genesis. Proceedings of the National Academy of Sciences USA, 95, 10632-10636.
119. Yu, B.D., Hess, J.L., Horning, S.E., Brown, G.A. & Korsmeyer, S.J. (1995) Altered Hox expression and segmental identity in Mll-mutant mice. Nature, 378, 505-508.
120. Zeleznik-Le, N.J., Harden, A.M. & Rowley, J.D. (1994) 11q23 translocations split the 'AT-hook' cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proccedings of the National Academy of Sciences USA, 91, 10610-10614.
121. Ziemin-van der Poel, S., McCabe, N.R., Gill, H.J., Espinosa, R. III, Patel, Y., Harden, A., Rubinelli, P., Smith, S.D., LeBeau, M.M., Rowley, J.D. & Diaz, M.O. (1991) Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proceedings of the National Academy of Sciences USA, 88, 10735-10739.